NEW YORK, Feb. 3, 2016 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Insys Therapeutics, Inc. ("Insys" or the "Company") (NASDAQ: INSY), concerning whether the board has breached its fiduciary duties to shareholders.
On April 24, 2015, the Southern Investigating Report Foundation ("SIRF") published an article titled "Insys Therapeutics and the New 'Killing It,'" reporting that many patients being treated with the Company's product Subsys died or suffered adverse events. On this news, Company stock lost approximately $6.00 per share.
On December 3, 2015, SIRF published an article titled "Murder Incorporated: Insys Therapeutics, Part I," reporting the Company operated a scheme to promote the illegal and improper off-label marketing and sale of Subsys. On this news, Company stock fell approximately $5.93 per share.
On January 25, 2016, SIRF published an article titled "The Brotherhood of Thieves: Insys Therapeutics," reporting that Company executives have pressured employees to promote the off-label marketing and sale of Subsys. On this news, Company stock lost an additional $1.07 per share.
Insys stock is currently trading at approximately, $14.38 per share, down from over $60 per share in April 2015.
Our investigation concerns whether the Company board of directors has breached its fiduciary duties to shareholders, grossly mismanaged the Company, and/or committed abuses of control in connection with the foregoing.
If you own Insys shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:
Robert I. Harwood, Esq.
Benjamin I. Sachs-Michaels, Esq.
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400
(212)935-7400
Email: bsachsmichaels@hfesq.com
Website: http://www.hfesq.com
Follow us on Twitter: @HarwoodFeffer
Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website (http://www.hfesq.com) for more information about the firm.
Attorney Advertising. The law firm responsible for this advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Logo - http://photos.prnewswire.com/prnh/20120215/MM54604LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/harwood-feffer-llp-announces-investigation-of-insys-therapeutics-inc-300214746.html
SOURCE Harwood Feffer LLP
